about
Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in menMinor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipesVariation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypesSmoking during pregnancy: postnatal effects on arousal and attentional brain systemsPermissive nicotine regulation as a complement to traditional tobacco controlPedunculopontine arousal system physiology-Effects of psychostimulant abuseNicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug useMechanisms underlying regulation of respiratory pattern by nicotine in preBötzinger complexA unified framework for addiction: vulnerabilities in the decision processNicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disordersGenes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses.Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell)Salivary cotinine concentrations in daily smokers in Barcelona, Spain: a cross-sectional study.The Health Effect of Psychostimulants: A Literature ReviewCigarette smoking.Policy options to reduce tobacco-caused mortality.Hypothesis for temporal displacement of metabolic and neuronal accommodation in smoking addiction.Acetylcholine receptors and myasthenia.Biomonitoring of urinary cotinine concentrations associated with plasma levels of nicotine metabolites after daily cigarette smoking in a male Japanese population.Nicotine and periodontal tissuesPosting behaviour patterns in an online smoking cessation social network: implications for intervention design and development.Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET.Glutamatergic and GABAergic metabolism in mouse brain under chronic nicotine exposure: implications for addictionRole of a genetic variant on the 15q25.1 lung cancer susceptibility locus in smoking-associated nasopharyngeal carcinoma.Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function.Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.Hormones, nicotine, and cocaine: clinical studies.Neural reward and punishment sensitivity in cigarette smokers.Genetic influences on smoking: candidate genes.Applying genetic approaches to the treatment of nicotine dependence.Stress trajectories, health behaviors, and the mental health of black and white young adults.Prospective predictors of quitting behaviours among adult smokers in six cities in China: findings from the International Tobacco Control (ITC) China Survey.Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in miceDifferentiating the rapid actions of cocaine.Smoking Behavior and Alcohol Consumption in Individuals With Panic Attacks.Effects of nicotine administration in a mouse model of familial hypertrophic cardiomyopathy, α-tropomyosin D175N.Therapeutic options and challenges for substances of abuse.Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent womenThe most important and influential papers in tobacco control: results of an online poll
P2860
Q24541397-573397E8-6B26-4294-A018-0A4A43860975Q24551187-7C2622AC-06F1-4342-9C8F-04D79A1B82ABQ24601922-823A7E91-CFB2-44C3-861D-5F1220C477FBQ24604317-A227C093-0523-4035-8AA1-B0ED95D12D96Q24802184-E150DBB3-DEFA-4463-AFD2-EE4C96C56896Q26771407-63F2F956-3276-434E-994A-E852AA129A9DQ26782271-BBF38ECA-DEAB-4FA1-AFDC-F51E6D852F39Q28366153-84D5CF76-E9A6-4A07-9345-5662534459EEQ28680729-CAA20BCA-14EC-4C75-B6E3-EE7C3DB368E1Q30372351-49EA3B2F-F391-48F1-98D1-D285B26A1109Q30454318-63A2EDE1-72B7-4070-AD11-A284795F3E21Q30834928-791064E4-9AE1-4BD8-A9B4-4448C056B863Q33499895-D5203BC9-29C0-4D4D-A9CE-84E42CBE76B4Q33677986-3A403C1B-D168-4EE9-BBC4-A63BF6FBC3EFQ33713902-90A8E1D0-E6EE-4C88-85AD-58CC90514532Q33744373-C4F03E29-9E77-4263-9CFF-886B5EA530DDQ33815480-463D502C-F8B0-4E08-AA35-64E2C85BA2CFQ33862589-76C96692-4074-420E-A1BE-AD585E1E1B98Q34070307-C986D561-48B5-4270-A826-E34866D6B7ACQ34104781-342CC3E0-0FF1-4668-A7BC-5721836FC2E3Q34142262-CDA69A6F-D73E-4324-AFE1-481CAC975598Q34310935-FED8022A-FD63-4F90-8C0A-2A8F4CC472A2Q34359105-BDD89A0D-38DB-44C5-BA12-85322555A546Q34373662-10D9EC43-4929-415B-9001-F842A9F473C4Q34458445-663FD3AE-EF44-4411-B1FB-F822ACD899EBQ34458500-C3B8E344-B8EF-44D3-B787-5D1398A9B98BQ34501147-5708CF68-A2FF-4FAF-8D4C-FEC8D9C8B225Q34643948-38EC353B-8E05-4228-910F-BECBC3C0EF12Q34808522-D00C3952-2032-484A-B5DE-897EDD2CC0C8Q34938233-68CE882B-B6E8-4A11-BD1F-0D11D8519183Q34963561-1677D092-B8FD-4DEB-85FE-3F791D71E6DEQ34990317-E9D66D39-704B-470C-8E5B-7F7FBB5D7ED3Q35024053-B6C80DE3-A6E5-4359-9722-E8D0B9498651Q35054656-87C0CED8-66D7-401B-B5A4-84B6F9EEB1F7Q35161471-8D765651-5786-41AC-9EBD-A85D49979D7AQ35207539-CE8984D3-1903-44BA-8367-1B9927F6DBA8Q35396585-2CF33F58-D7C7-490F-99C9-B79C60197B5AQ35454891-19740678-C5A2-4784-9B39-77921E47BA4CQ35473808-AF66D45C-5F82-499C-8D0A-85CCE947A8CDQ35539515-99042693-C9B7-4F77-977F-3A2FC4AF160B
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Pharmacology of nicotine: addiction and therapeutics.
@en
type
label
Pharmacology of nicotine: addiction and therapeutics.
@en
prefLabel
Pharmacology of nicotine: addiction and therapeutics.
@en
P1476
Pharmacology of nicotine: addiction and therapeutics.
@en
P2093
Benowitz NL
P304
P356
10.1146/ANNUREV.PA.36.040196.003121
P577
1996-01-01T00:00:00Z